Target intelligence / Profile preview

MicroRNA 3135a (MIR3135A)

Target
MIR3135A
Molecular classification
MicroRNA (miRNA), Non-coding RNA
01

Overview

MicroRNA 3135a is a short (~20-24 nucleotide) non-coding RNA classified as a human microRNA (miRNA)[1][3]. MicroRNAs are transcribed primarily by RNA polymerase II as part of longer primary transcripts (pri-miRNAs), which are cleaved in the nucleus by Drosha to generate precursor miRNAs. These are exported to the cytoplasm, further processed by Dicer, and the mature miRNA is then loaded onto the RISC complex, which targets specific mRNAs by imperfect base pairing, resulting in gene silencing via translational inhibition or mRNA destabilization[1][6][7]. While thousands of microRNAs are cataloged in the human genome, current literature on MIR3135A identifies an association with autism spectrum disorder, but detailed regulatory targets, interacting drugs, or mechanistic therapeutic roles are largely unknown.

Other names
MIR3135hsa-mir-3135hsa-mir-3135amicroRNA 3135microRNA 3135aMIR3135A
02

Mechanism of action

Not directly targeted by drugs; general microRNA mechanism involves incorporation into the RNA-induced silencing complex (RISC), which binds to complementary sequences on target mRNAs to inhibit their translation or promote their degradation

03

Biological functions

Post-transcriptional regulation of gene expression through mRNA degradation or translational repressionRegulation of diverse cellular processes, as is typical for microRNAs
04

Disease associations

Some association reported with autism spectrum disordermicroRNAs are frequently implicated in various diseases through gene regulation, but MIR3135A appears specifically linked to autism spectrum disorder in current literature

Beyond the preview

Go deeper on MicroRNA 3135a (MIR3135A).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on MicroRNA 3135a (MIR3135A).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call